About BML, Inc. 
BML, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.05%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
35,787 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,249 Million
Pharmaceuticals & Biotechnology
JPY 145,883 Million (Small Cap)
21.00
NA
0.00%
-0.51
6.34%
1.16






